We’re committed to helping patients like you gain access to treatment. MyNavCare provides resources to help you understand your insurance coverage and explore sources of financial support, including co-pay assistance.
With MyNavCare, you can receive personalized support throughout your treatment journey from a dedicated team that cares.
Your healthcare provider is your main source for treatment information. With MyNavCare, you gain access to additional resources and medication information.
MyNavCare may be able to help uninsured or underinsured patients receive financial assistance and information. This includes:
Your Patient Engagement Liaison is an experienced nurse and trained in treatment support as it relates to your specific care.‡ They’re dedicated to you, helping to:
*Based on eligibility requirements and Terms and Conditions.
†Eligibility criteria is determined by each independent third-party foundation. MyNavCare does not determine eligibility and cannot guarantee foundations will offer assistance.
‡Patient Engagement Liaisons are provided by MyNavCare Patient Support and do not work under the direction of your doctor or provide medical advice. Patients should speak with their doctor about any treatment-related questions.
Contact a MyNavCare Support Specialist by calling 1-866-NAV-CAR1 (1-866-628-2271), Monday-Friday, 8 AM-8 PM ET. You can also visit MyNavCare.com to learn more.
Download our EPKINLY What to Expect Guide and ask your healthcare provider about getting started.
There are many other resources and tools that can provide support for you and your care partner. The following are some organizations that can help you and your care partner connect with others like you, as well as provide information and tips throughout your treatment.
There are many available resources that may be helpful to patients, families, and care partners dealing with cancer. The above resources are not controlled, owned, or endorsed by Genmab/AbbVie, and Genmab/AbbVie is not responsible for their content.
EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment (refractory), and who have received 2 or more treatments for their cancer.
EPKINLY is approved based on patient response data. A study is ongoing to confirm the clinical benefit of EPKINLY. It is not known if EPKINLY is safe and effective in children.
Due to the risk of CRS, you will receive EPKINLY on a “step-up” dosing schedule. The step-up dosing schedule is when you receive smaller “step-up” doses of EPKINLY on day 1 and day 8 of your first cycle of treatment (cycle 1). You will receive your first full dose of EPKINLY on day 15 of cycle 1. If your dose of EPKINLY is delayed for any reason, you may need to repeat the step-up dosing schedule. Before each dose in cycle 1, you will receive medicines to help reduce your risk of CRS. Your healthcare provider will decide if you need to receive medicine to help reduce your risk of CRS with future cycles.
Due to the risk of CRS and neurologic problems, you should be hospitalized for 24 hours after receiving your first full dose of EPKINLY on day 15 of cycle 1. Your healthcare provider will monitor you for symptoms of CRS and neurologic problems during treatment with EPKINLY, as well as other side effects, and treat you if needed. Your healthcare provider may temporarily stop or completely stop your treatment with EPKINLY if you develop CRS, neurologic problems, or any other side effects that are severe.
Do not drive or use heavy or potentially dangerous machinery if you develop dizziness, confusion, tremors, drowsiness, or any other symptoms that impair consciousness until your symptoms go away. These may be symptoms of CRS or neurologic problems.
EPKINLY can also cause other serious side effects, including:
Your healthcare provider may temporarily stop or completely stop treatment with EPKINLY if you develop certain side effects.
Before you receive EPKINLY, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of EPKINLY include CRS, tiredness, muscle and bone pain, injection site reactions, fever, stomach-area (abdominal) pain, nausea, and diarrhea.
These are not all the possible side effects of EPKINLY. Call your doctor for medical advice about side effects.
You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to Genmab US, Inc. at 1-855-4GENMAB (1-855-443-6622).
Please see Medication Guide, including Important Warnings.
